GDF15 and hepatocellular carcinoma: Targeted delivery of CRISPR/Cas9 against GDF15 using nanocapsules coated with HCC‐specific SP94 peptides, enhances immune cell infiltration in HCC and promotes favorable immune microenvironment changes, as evidenced by cytometry by time‐of‐flight (CyTOF) analysis [635].